As we, the percentages of CD8+ T cells (CD3+CD8+) and actively proliferating T cells (CD8+Ki67+) were slightly increased in the Mel@AVB group, which may be attributed to the suppression of CD8+ T cells by programmed death pathway on tumor cells (Fig. 5, E and F). This evidence concerns the gene MKI67 and neoplasm.